[Use of new antiviral preparations, nuclease enzymes, in neuroviral infections].
D000257:Adenoviridae Infections / Q000188:drug therapy; D000367:Age Factors; D000818:Animals; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002493:Central Nervous System Diseases / Q000188:drug therapy; D002642:Chick Embryo; D002986:Clinical Trials as Topic; D003851:Deoxyribonucleases / Q000008:administration & dosage / Q000627:therapeutic use*; D003888:Desensitization, Immunologic; D004675:Encephalitis, Tick-Borne / Q000188:drug therapy; D004679:Encephalomyelitis / Q000188:drug therapy; D004769:Enterovirus Infections / Q000188:drug therapy; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans; D008587:Meningitis, Viral / Q000188:drug therapy; D051379:Mice; D011051:Poliomyelitis / Q000188:drug therapy; D012260:Ribonucleases / Q000008:administration & dosage / Q000627:therapeutic use*; D013329:Structure-Activity Relationship; D014777:Virus Diseases / Q000188:drug therapy*; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D003851:Deoxyribonucleases; D012260:Ribonucleases
Primenenie novykh protivovirusnykh preparatov--nukleazov-fermentov pri neĭrovirusnykh infektsiiakh